Pressure-response analysis of anesthetic gases xenon and nitrous oxide on urate oxidase: A crystallographic study

FASEB Journal

Volumn 25, Issue 7, 2011, Pages 2266-2275

  Marassio, Guillaume ^a,b   Prangé, Thierry ^c   David, Hélène N ^a,b   Sopkova De Oliveira Santos, Jana ^d   Gabison, Laure ^c   Delcroix, Nicolas ^b   Abraini, Jacques H ^a,b,e   Colloc'h, Nathalie ^a,b  

^a UCBN   (France)

^b UNIVERSITÉ DE CAEN   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d CENTRE D ETUDES ET DE RECHERCHE SUR LE MÉDICAMENT DE NORMANDIE   (France)

^e CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

Author keywords

Dose response; Enzymatic activity; Hydrophobic cavity; Inert gas; Neuroprotection

Indexed keywords

NITROUS OXIDE; URATE OXIDASE; XENON;

ANESTHESIA MECHANISM; ARTICLE; DOSE RESPONSE; DRUG BINDING SITE; DRUG MECHANISM; DRUG PROTEIN BINDING; ENZYME ACTIVITY; GAS ANALYSIS; HYDROPHOBICITY; INHALATION ANESTHESIA; NEUROPROTECTION; PRESSURE; PRIORITY JOURNAL; PROTEIN FUNCTION; X RAY CRYSTALLOGRAPHY;

ALGORITHMS; ANESTHETICS, INHALATION; BINDING SITES; BINDING, COMPETITIVE; BIOCATALYSIS; CATALYTIC DOMAIN; CRYSTALLOGRAPHY, X-RAY; FUNGAL PROTEINS; KINETICS; MODELS, MOLECULAR; NITROUS OXIDE; PRESSURE; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; URATE OXIDASE; XENON;

EID: 79960170844     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-183046     Document Type: Article

References (49)

1. Cullen, S. C., and Gross, E. G. (1951) The anesthetic properties of xenon in human and animal beings, with additional observations on krypton. Science 113, 580-582
2. David, H. N., Leveillé, F, Chazalviel, L., MacKenzie, E. T., Buisson, A., Lemaire, M., and Abraini, J. H. (2003) Reduction of ischemic brain damage by nitrous oxide and xenon. J. Cereb. Blood Flow Metab. 23, 1168-1173
3. Dyck, P. J., Grina, L. A., Lambert, E. H., Calder, C. S., Oviatt, K., Rehder, K., Lund, B. A., and Skau, K. A. (1980) Nitrous oxide neurotoxicity studies in man and rat. Anesthesiology 53, 205-209
4. Fenster, M. N. (1951) Nitrous oxide as an inhalation anesthetic. J. Med. Soc. N .J. 48, 281
5. Hopkins, P. M. (2005) Nitrous oxide: a unique drug of continuing importance for anaesthesia. Best Pract. Res. Clin. Anaesthesiol. 19, 381-389
6. Franks, N. P., Dickinson, R., de Sousa, S. L., Hall, A. C., and Lieb, W. R. (1998) How does xenon produce anaesthesia? Nature 396, 324
7. Jevtovic-Todorovic, V., Todorovic, S. M., Mennerick, S., Powell, S., Dikranian, K., Benshoff, N., Zorumski, C. F., and Olney, J. W. (1998) Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat. Med. 4, 460-463
8. Yamakura, T., and Harris, R. A. (2000) Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol. Anesthesiology 93, 1095-1101
9. David, H. N., Haelewyn, B., Risso, J. J., Colloc'h, N., and Abraini, J. H. (2010) Xenon is an inhibitor of tissue-plasminogen activator: adverse and beneficial effects in a rat model of thromboembolic stroke. J. Cereb. Blood Flow Metab. 30, 718-728
10. Olney, J. W., Labruyere, J., Wang, G., Wozniak, D. F., Price, M. T., and Sesma, M. A. (1991) NMDA antagonist neurotoxicity: mechanism and prevention. Science 254, 1515-1518
11. Abraini, J. H., David, H. N., and Lemaire, M. (2005) Potentially neuroprotective and therapeutic properties of nitrous oxide and xenon. Ann. N. Y. Acad. Sci. 1053, 289-300
12. Cattano, D., Valleggi, S., Ma, D., Kastsiuchenka, O., Abramo, A., Sun, P., Cavazzana, A. O., Natale, G., Maze, M., and Giunta, F. (2008) Xenon induces transcription of ADNP in neonatal rat brain. Neurosci. Lett. 440, 217-221
13. David, H. N., Haelewyn, B., Rouillon, C., Lecoq, M., Chazalviel, L., Apiou, G., Risso, J. J., Lemaire, M., and Abraini, J. H. (2008) Neuroprotective effects of xenon: a therapeutic window of opportunity in rats subjected to transient cerebral ischemia. FASEB J. 22, 1275-1286
14. Dickinson, R., Peterson, B. K., Banks, P., Simillis, C., Martin, J. C., Valenzuela, C. A., Maze, M., and Franks, N. P. (2007) Competitive inhibition at the glycine site of the N-methyl-Daspartate receptor by the anesthetics xenon and isoflurane: evidence from molecular modeling and electrophysiology. Anesthesiology 107, 756-767 (Pubitemid 351325968)
15. Dinse, A., Fohr, K. J., Georgieff, M., Beyer, C., Bulling, A., and Weigt, H. U. (2005) Xenon reduces glutamate-, AMPA-, and kainate-induced membrane currents in cortical neurones. Br. J. Anaesth. 94, 479-485
16. Haelewyn, B., David, H. N., Rouillon, C., Chazalviel, L., Lecocq, M., Risso, J. J., Lemaire, M., and Abraini, J. H. (2008) Neuroprotection by nitrous oxide: facts and evidence. Crit. Care Med. 36, 2651-2659
17. Homi, H. M., Yokoo, N., Ma, D., Warner, D. S., Franks, N. P., Maze, M., and Grocott, H. P. (2003) The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice. Anesthesiology 99, 876-881 (Pubitemid 37186078)
18. Luo, Y., Ma, D., Ieong, E., Sanders, R. D., Yu, B., Hossain, M., and Maze, M. (2008) Xenon and sevoflurane protect against brain injury in a neonatal asphyxia model. Anesthesiology 109, 782-789
19. Ma, D., Yang, H., Lynch, J., Franks, N. P., Maze, M., and Grocott, H. P. (2003) Xenon attenuates cardiopulmonary bypass-induced neurologic and neurocognitive dysfunction in the rat. Anesthesiology 98, 690-698 (Pubitemid 36262596)
20. Dirnagl, U., Iadecola, C., and Moskowitz, M. A. (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391-397
21. Sonner, J. M., Cascio, M., Xing, Y., Fanselow, M. S., Kralic, J. E., Morrow, A. L., Korpi, E. R., Hardy, S., Sloat, B., Eger, E. I., 2nd, and Homanics, G. E. (2005) Alpha 1 subunitcontaining GABA type A receptors in forebrain contribute to the effect of inhaled anesthetics on conditioned fear. Mol. Pharmacol. 68, 61-68
22. Colloc'h, N., Sopkova-de Oliveira Santos, J., Retailleau, P., Vivares, D., Bonnete, F., Langlois d'Estainto, B., Gallois, B., Brisson, A., Risso, J. J., Lemaire, M., Prange, T., and Abraini, J. H. (2007) Protein crystallography under xenon and nitrous oxide pressure: comparison with in vivo pharmacology studies and implications for the mechanism of inhaled anesthetic action. Biophys. J. 92, 217-224
23. Hayakawa, N., Kasahara, T., Hasegawa, D., Yoshimura, K., Murakami, M., and Kouyama, T. (2008) Effect of xenon binding to a hydrophobic cavity on the proton pumping cycle in bacteriorhodopsin. J. Mol. Biol. 384, 812-823
24. Moschetti, T., Mueller, U., Schulze, J., Brunori, M., and Vallone, B. (2009) The structure of neuroglobin at high Xe and Kr pressure reveals partial conservation of globin internal cavities. Biophys. J. 97, 1700-1708
25. Olia, A. S., Casjens, S., and Cingolani, G. (2009) Structural plasticity of the phage P22 tail needle gp26 probed with xenon gas. Protein Sci. 18, 537-548
26. Prangé, T, Schiltz, M., Pernot, L., Colloc'h, N., Longhi, S., Bourguet, W., and Fourme, R. (1998) Exploring hydrophobic sites in proteins with xenon or krypton. Proteins 30, 61-73
27. Schiltz, M., Fourme, R., Broutin, I., and Prangé, T (1995) The catalytic site of serine proteinases as a specific binding cavity for xenon. Structure 3, 309-316
28. Colloc'h, N., El Hajji, M., Bachet, B., L'Hermite, G., Schiltz, M., Prangé, T, Castro, B., and Mornon, J. P. (1997) Crystal structure of the protein drug urate oxidase-inhibitor complex at 2.05 Å resolution. Nat. Struc. Biol. 4, 947-952
29. Berendes, R., Voges, D., Demange, P., Huber, R., and Burger, A. (1993) Structure-function analysis of the ion channel selectivity filter in human annexin V. Science 262, 427-430 (Pubitemid 23353386)
30. Voges, D., Berendes, R., Demange, P., Benz, J., Gottig, P., Liemann, S., Huber, R., and Burger, A. (1995) Structure and function of the ion channel model system annexin V. Adv. Enzymol. Relat. Areas Mol. Biol. 71, 209-239
31. Miller, K. W. (2002) The nature of sites of general anaesthetic action. Brit. J. Anaesthesia 89, 17-31
32. Schiltz, M., Prangé, T, and Fourme, R. (1994) On the preparation and x-ray data collection of isomorphous xenon derivatives. J. Appl. Cryst. 27, 950-960
33. Otwinowski, Z., and Minor, W. (1997) Processing of X-ray diffraction data collected in the oscillation mode. Methods Enzymol. 276, 307-326 (Pubitemid 27085611)
34. Leslie, A. G. (2006) The integration of macromolecular diffraction data. Acta Crystallogr. D 62, 48-57
35. Kabsch, W. (2010) Xds. Acta Crystallogr. D 66, 125-132
36. Murshudov, G N, Vagin, A. A., and Dodson, E. J. (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D 53, 240-255 (Pubitemid 27235885)
37. Collaborative Computational Project Number 4 (1994) The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760-763
38. Emsley, P., and Cowtan, K. (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126-2132 (Pubitemid 41742764)
39. DeLano, W. L. (2002) The PyMol Molecular Graphics System, DeLano Scientific, Palo Alto, CA, USA; http://www.pymol.org
40. Kleywegt, G. J., and Jones, T. A. (1996) xdlMAPMAN and xdlDATAMAN - programs for reformatting, analysis and manipulation of biomacromolecular electron-density maps and reflection data sets. Acta Crystallogr. 52, 826-828
41. + channel-Fab complex at 2.0 A resolution. Nature 4, 43-48
42. Kleywegt, G. J., and Jones, T. A. (1994) Detection, delineation, measurement and display of cavities in macromolecular structures. Acta Crystallogr. D 50, 178-185
43. Girard, E., Marchal, S., Perez, J., Finet, S., Kahn, R., Fourme, R., Marassio, G., Dhaussy, A. C., Prange, T., Giffard, M., Dulin, F., Bonnete, F., Lange, R., Abraini, J. H., Mezouar, M., and Colloc'h, N. (2010) Structure-function perturbation and dissociation of tetrameric urate oxidase by high hydrostatic pressure. Biophys. J. 98, 2365-2373
44. Campagna, J. A., Miller, K. W., and Forman, S. A. (2003) Mechanisms of actions of inhaled anesthetics. N. Engl. J. Med. 348, 2110-2124
45. + channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol. Pharmacol. 65, 443-452
46. Vedula, L. S., Brannigan, G., Economou, N. J., Xi, J., Hall, M. A., Liu, R., Rossi, M. J., Dailey, W. P., Grasty, K. C., Klein, M. L., Eckenhoff, R. G., and Loll, P. J. (2009) A unitary anesthetic binding site at high resolution. J. Biol. Chem. 284, 24176-24184
47. Hubbard, S. J., and Argos, P. (1996) A functional role for protein cavities in domain: domain motions. J. Mol. Biol. 261, 289-300
48. Eckenhoff, R. G. (2001) Promiscuous ligands and attractive cavities: how do the inhaled anesthetics work? Mol. Interv. 1, 258-268
49. Johansson, J. S., Manderson, G. A., Ramoni, R., Grolli, S., and Eckenhoff, R. G. (2005) Binding of the volatile general anesthetics halothane and isoflurane to a mammalian beta-barrel protein. FEBS J. 272, 573-581